| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |